TLDR Accurate method measures finasteride levels in human plasma using gas chromatography-mass spectrometry.
This 1995 paper describes a sensitive and accurate method for determining finasteride levels in human plasma using gas chromatography-mass spectrometry and a deuterated internal standard. The method was applied to the determination of the pharmacokinetic profile of finasteride in five male volunteers treated with a single oral 5-mg dose of the drug, and the results were in good agreement with previous studies. The method is suitable for routine determination of finasteride at picogram levels.
19 citations
,
October 1994 in “The Journal of Clinical Endocrinology and Metabolism” 61 citations
,
September 1994 in “The Journal of Clinical Endocrinology and Metabolism”
45 citations
,
August 1994 in “Journal of Chromatography B: Biomedical Sciences and Applications” Method detects finasteride in plasma and semen with high sensitivity and accuracy.
1040 citations
,
October 1992 in “The New England Journal of Medicine” Finasteride effectively treats BPH but may increase sexual dysfunction risk.
19 citations
,
May 1991 in “Journal of Chromatography B: Biomedical Sciences and Applications” Reliable method detects finasteride in human plasma at low doses.
23 citations
,
August 2005 in “Expert opinion on pharmacotherapy” New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.
9 citations
,
February 2018 in “Journal of Pharmaceutical and Biomedical Analysis” Quick, selective detection of tadalafil and finasteride in human plasma developed.
18 citations
,
April 2010 in “Journal of Chromatography B” New method measures finasteride in blood quickly and accurately.
20 citations
,
August 2014 in “Talanta” The method effectively measures drug impact on DHT levels in prostate treatments.
2 citations
,
November 2017 in “Biotechnology Letters” Researchers found four natural compounds that can change DHT levels in prostate cancer cells.